Premium Longevity Program

Qualevita's most comprehensive health assessment, analysing over 200 biomarkers with a three-hour physician consultation covering deep hormonal, metabolic, nutritional, and inflammatory profiling for individuals pursuing optimal healthspan.

The Premium Longevity Program represents the most thorough health assessment available at Qualevita, designed for individuals who view health optimisation as a serious investment. The 200+ biomarker panel goes far beyond standard medical screening to include comprehensive hormonal profiling (reproductive, adrenal, thyroid axes), advanced cardiovascular risk markers (apolipoproteins, lipoprotein(a), homocysteine), detailed micronutrient analysis, inflammatory and oxidative stress markers, immune function indicators, and metabolic health parameters including insulin sensitivity metrics. The centrepiece is a three-hour physician consultation — a depth of clinical time that is virtually impossible to obtain in conventional healthcare. This extended consultation allows the physician to review every marker in detail, explore interconnections between systems (for example, the relationship between thyroid function, sex hormones, and metabolic rate), discuss family history and genetic predispositions, and develop a genuinely individualised health optimisation strategy. The physician team includes specialists trained in anti-ageing medicine, hormone optimisation, and preventive health under the clinical approach developed with Dr. Thierry Hertoghe. The program includes a comprehensive written report with prioritised recommendations spanning nutrition, supplementation protocols, exercise prescription, sleep optimisation, stress management, and referrals for specialist follow-up where indicated. At EUR 4,950, this is a premium investment suited to executives, entrepreneurs, and health-focused individuals who want the most detailed picture of their current biological status and a clear, evidence-based roadmap for extending their healthspan. A one-year plan with repeat testing and consultations is available for longitudinal tracking.